Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
| 35.56 BATS BZX Real-Time Price As of 3:31pm ET |  +0.42 / +1.20%Today’s Change | 27.87 Today|||52-Week Range 93.66 | -46.37% Year-to-Date |
Latest ARWR News | Press Releases
| Arrowhead Pharmaceuticals (ARWR) Q2 2022 Earnings Call Transcript May 11 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 35.14 |
| Today’s open | 34.07 |
| Day’s range | 33.93 - 36.42 |
| Volume | 14,826 |
| Average volume (3 months) | 778,535 |
| Market cap | $3.3B |
Data as of 3:31pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | -61.72% |
| Earnings growth (this year) | +13.68% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +57.16% |
| P/E ratio | NM |
| Price/Sales | 46.84 |
| Price/Book | 8.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NTLAIntellia Therapeutic... | -1.31 | -2.75% |
| ZLABZai Lab Ltd | +0.72 | +2.02% |
| BPMCBlueprint Medicines ... | +0.33 | +0.58% |
| ---- |
Data as of 3:31pm ET, 05/20/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.51 |
| Annual revenue (last year) | $138.3M |
| Annual profit (last year) | -$140.8M |
| Net profit margin | -101.85% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Pasadena, California |
Forecasts
